ArticleDiabetes care2026

Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile.

Laura M Jacobsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.